Literature DB >> 15767577

The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation.

Barrington G Burnett1, Randall N Pittman.   

Abstract

The polyglutamine-containing neurodegenerative protein ataxin 3 (AT3) has deubiquitylating activity and binds ubiquitin chains with a preference for chains of four or more ubiquitins. Here we characterize the deubiquitylating activity of AT3 in vitro and show it trims/edits K48-linked ubiquitin chains. AT3 also edits polyubiquitylated (125)I-lysozyme and decreases its degradation by proteasomes. Cellular studies show that endogenous AT3 colocalizes with aggresomes and preaggresome particles of the misfolded cystic fibrosis transmembrane regulator (CFTR) mutant CFTRDeltaF508 and associates with histone deacetylase 6 and dynein, proteins required for aggresome formation and transport of misfolded protein. Small interfering RNA knockdown of AT3 greatly reduces aggresomes formed by CFTRDeltaF508, demonstrating a critical role of AT3 in this process. Wild-type AT3 restores aggresome formation; however, AT3 with mutations in the active site or ubiquitin interacting motifs cannot restore aggresome formation in AT3 knockdown cells. These same mutations decrease the association of AT3 and dynein. These data indicate that the deubiquitylating activity of AT3 and its ubiquitin interacting motifs as well play essential roles in CFTRDeltaF508 aggresome formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767577      PMCID: PMC555481          DOI: 10.1073/pnas.0407252102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  Aggresomes, inclusion bodies and protein aggregation.

Authors:  R R Kopito
Journal:  Trends Cell Biol       Date:  2000-12       Impact factor: 20.808

2.  Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48.

Authors:  Ernst Jarosch; Christof Taxis; Corinna Volkwein; Javier Bordallo; Daniel Finley; Dieter H Wolf; Thomas Sommer
Journal:  Nat Cell Biol       Date:  2002-02       Impact factor: 28.824

3.  Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.

Authors:  H Fujigasaki; T Uchihara; S Koyano; K Iwabuchi; S Yagishita; T Makifuchi; A Nakamura; K Ishida; S Toru; S Hirai; K Ishikawa; T Tanabe; H Mizusawa
Journal:  Exp Neurol       Date:  2000-10       Impact factor: 5.330

4.  Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice.

Authors:  A Abel; J Walcott; J Woods; J Duda; D E Merry
Journal:  Hum Mol Genet       Date:  2001-01-15       Impact factor: 6.150

5.  VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration.

Authors:  M Hirabayashi; K Inoue; K Tanaka; K Nakadate; Y Ohsawa; Y Kamei; A H Popiel; A Sinohara; A Iwamatsu; Y Kimura; Y Uchiyama; S Hori; A Kakizuka
Journal:  Cell Death Differ       Date:  2001-10       Impact factor: 15.828

6.  An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel beta -fibrils.

Authors:  A E Bevivino; P J Loll
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

7.  Cytoplasmic dynein, the dynactin complex, and kinesin are interdependent and essential for fast axonal transport.

Authors:  M Martin; S J Iyadurai; A Gassman; J G Gindhart; T S Hays; W M Saxton
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

8.  Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions.

Authors:  Thorsten Schmidt; Katrin S Lindenberg; Antje Krebs; Ludger Schöls; Franco Laccone; Jochen Herms; Martin Rechsteiner; Olaf Riess; G Bernhard Landwehrmeyer
Journal:  Ann Neurol       Date:  2002-03       Impact factor: 10.422

9.  Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration.

Authors:  Bernadette H LaMonte; Karen E Wallace; Beth A Holloway; Spencer S Shelly; Jennifer Ascaño; Mariko Tokito; Thomas Van Winkle; David S Howland; Erika L F Holzbaur
Journal:  Neuron       Date:  2002-05-30       Impact factor: 17.173

10.  Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera.

Authors:  R García-Mata; Z Bebök; E J Sorscher; E S Sztul
Journal:  J Cell Biol       Date:  1999-09-20       Impact factor: 10.539

View more
  72 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

2.  Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia.

Authors:  Cristy Tower; Lianwu Fu; Rachel Gill; Mark Prichard; Mathieu Lesort; Elizabeth Sztul
Journal:  Neurobiol Dis       Date:  2010-08-20       Impact factor: 5.996

3.  The UBX protein SAKS1 negatively regulates endoplasmic reticulum-associated degradation and p97-dependent degradation.

Authors:  David P LaLonde; Anthony Bretscher
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

4.  Long Term Aggresome Accumulation Leads to DNA Damage, p53-dependent Cell Cycle Arrest, and Steric Interference in Mitosis.

Authors:  Meng Lu; Chiara Boschetti; Alan Tunnacliffe
Journal:  J Biol Chem       Date:  2015-09-25       Impact factor: 5.157

5.  The de-ubiquitinating enzyme ataxin-3 does not modulate disease progression in a knock-in mouse model of Huntington disease.

Authors:  Li Zeng; Sara J Tallaksen-Greene; Bo Wang; Roger L Albin; Henry L Paulson
Journal:  J Huntingtons Dis       Date:  2013

6.  Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.

Authors:  Yuxin Mao; Francesca Senic-Matuglia; Pier Paolo Di Fiore; Simona Polo; Michael E Hodsdon; Pietro De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

Review 7.  Ubiquitin-like modifiers and their deconjugating enzymes in medically important parasitic protozoa.

Authors:  Elizabeth L Ponder; Matthew Bogyo
Journal:  Eukaryot Cell       Date:  2007-09-28

Review 8.  Aggresome formation and neurodegenerative diseases: therapeutic implications.

Authors:  J A Olzmann; L Li; L S Chin
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 9.  Class IIA HDACs in the regulation of neurodegeneration.

Authors:  Nazanin Majdzadeh; Brad E Morrison; Santosh R D'Mello
Journal:  Front Biosci       Date:  2008-01-01

10.  PolyQ-expanded ataxin-3 interacts with full-length ataxin-3 in a polyQ length-dependent manner.

Authors:  Na-Li Jia; Er-Kang Fei; Zheng Ying; Hong-Feng Wang; Guang-Hui Wang
Journal:  Neurosci Bull       Date:  2008-08       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.